JAC Advance Access originally published online on December 21, 2007
Journal of Antimicrobial Chemotherapy 2008 61(2):428-435; doi:10.1093/jac/dkm497
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original research |
Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use
1 Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands 2 Institute for Medical Technology Assessment, Erasmus University Medical Centre, Rotterdam, The Netherlands 3 Department of Epidemiology and Biostatistics, Erasmus University Medical Centre, Rotterdam, The Netherlands
Received 30 August 2007; returned 30 October 2007; revised 23 September 2007; accepted 26 November 2007
* Corresponding author. Tel: +31-10-463-3874; Fax: +31-10-463-3875; E-mail: j.kerremans{at}erasmusmc.nl
Introduction: Rapid bacterial identification and susceptibility tests can lead to earlier microbiological diagnosis and pathogen-directed, appropriate therapy. We studied whether accelerated diagnostics affected antibiotic use and patient outcomes.
Patients and methods: A prospective randomized clinical trial was performed over a 2-year period. Inpatients were selected on the basis of a positive culture from normally sterile body fluids and randomly assigned to either a rapid intervention arm or the control arm. The intervention arm used the Vitek 2 automated identification and susceptibility testing device, combined with direct inoculation of blood cultures. In the control arm, the Vitek 1 system inoculated from subcultures was used. Follow-up was 4 weeks after randomization.
Results: A total of 1498 patients were randomized: 746 in the intervention arm and 752 in the control arm. For susceptibility testing, the rapid arm was 22 h faster than the control arm, and for identification, it was 13 h faster (P < 0.0001). In the rapid arm, antibiotic use was 6 defined daily doses lower per patient than in the control arm (P = 0.012). Whereas antibiotics were switched more in the rapid group on the day of randomization (P = 0.006), in the control group they were switched more on day two (P = 0.02). Mortality rates did not differ significantly between the two groups (17.6% versus 15.2%).
Conclusions: While rapid bacterial identification and susceptibility testing led to earlier changes and a significant reduction in antibiotic use, they did not reduce mortality.
Keywords: diagnostics , antimicrobial management , antibiotic usage
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. A. Mittman, R. C. Huard, P. Della-Latta, and S. Whittier Comparison of BD Phoenix to Vitek 2, MicroScan MICroSTREP, and Etest for Antimicrobial Susceptibility Testing of Streptococcus pneumoniae J. Clin. Microbiol., November 1, 2009; 47(11): 3557 - 3561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Kerremans, A. K. van der Bij, W. Goessens, H. A. Verbrugh, and M. C. Vos Needle-to-Incubator Transport Time: Logistic Factors Influencing Transport Time for Blood Culture Specimens J. Clin. Microbiol., March 1, 2009; 47(3): 819 - 822. [Abstract] [Full Text] [PDF]
|
|